Norway - Hospital Average Length of Stay for Malignant Neoplasm of Bladder
Since 2014, Norway Hospital Average Length of Stay for Malignant Neoplasm of Bladder decreased by 3.1% year on year. In 2019, the country was ranked number 31 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Bladder with 3.5 Days. Norway is overtaken by Israel, which was ranked number 30 with 4 Days and is followed by Netherlands with 3.3 Days. South Korea lead the ranking with 11.3 Days in 2019, that is stable compared to 2018. Iceland recorded the best 5 years average growth at +6.9% per year, while Mexico recorded the worst performance at -5% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 3.50 |
| 2018 | 3.60 |
| 2017 | 3.80 |
| 2016 | 3.80 |
| 2015 | 3.90 |
Download all data from 2000 to 2019
How does Norway rank in Hospital Average Length of Stay for Malignant Neoplasm of Bladder?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
11.30 | 2019 | +0.0 % | +0.7 % | View data | |
| 2 |
#2
Iceland
|
8.50 | 2019 | +2.4 % | +6.9 % | View data | |
| 30 |
#30
Israel
|
4.00 | 2019 | +0.0 % | -3.2 % | View data | |
| 31 |
#31
Norway
|
3.50 | 2019 | -2.8 % | -3.1 % | View data | |
| 32 |
#32
Netherlands
|
3.30 | 2019 | -5.7 % | -1.7 % | View data | |